Abstract:Abstract Combining multiple types of genomic, transcriptional, proteomic, and epigenetic datasets has the potential to reveal biological mechanisms across multiple scales, and may lead to more accurate models for clinical decision support. Developing efficient models that can derive clinical outcomes from high-dimensional data remains problematical; challenges include the integration of multiple types of omics data, inclusion of biological background knowledge, and developing machine learning models that are able to deal with this high dimensionality while having only few samples from which to derive a model. We developed DeepMOCCA, a framework for multi-omics cancer analysis. We combine different types of omics data using biological relations between genes, transcripts, and proteins, combine the multi-omics data with background knowledge in the form of protein–protein interaction networks, and use graph convolution neural networks to exploit this combination of multi-omics data and background knowledge. DeepMOCCA predicts survival time for individual patient samples for 33 cancer types and outperforms most existing survival prediction methods. Moreover, DeepMOCCA includes a graph attention mechanism which prioritizes driver genes and prognostic markers in a patient-specific manner; the attention mechanism can be used to identify drivers and prognostic markers within cohorts and individual patients. Author summary Linking the features of tumors to a prognosis for the patient is a critical part of managing cancer. Many methods have been applied to this problem but we still lack accurate prognostic markers for many cancers. We now have more information than ever before on the state of the cancer genome, the epigenetic changes in tumors, and gene expression at both RNA and protein levels. Here, we address the question of how this data can be used to predict cancer survival and discover which tumor genes make the greatest contribution to the prognosis in individual tumor samples. We have developed a computational model, DeepMOCCA, that uses artificial neural networks underpinned by a large graph constructed from background knowledge concerning the functional interactions between genes and their products. We show that with our method, DeepMOCCA can predict cancer survival time based entirely on features of the tumor at a cellular and molecular level. The method confirms many existing genes that affect survival but for some cancers suggests new genes, either not implicated in survival before or not known to be important in that particular cancer. The ability to predict the important features in individual tumors provided by our method raises the possibility of personalized therapy based on the gene or network dominating the prognosis for that patient.

Enhancing Breast Cancer Survival Prognosis Through Omic and Non-Omic Data Integration

Improving Breast Cancer Survival Analysis through Competition-Based Multidimensional Modeling

Integrating Somatic Mutations for Breast Cancer Survival Prediction Using Machine Learning Methods

Deep learning based feature-level integration of multi-omics data for breast cancer patients survival analysis

Evaluation of Machine Learning Algorithms for the Prognosis of Breast Cancer from the Surveillance, Epidemiology, and End Results Database

Assessing the Effect of Data Integration on Predictive Ability of Cancer Survival Models

Development of Omics Data Based Survival Models for Four Female Cancers Using Machine Learning Approaches

Abstract 5395: Improving survival prediction using flexible late fusion machine learning framework for multi-omics data integration

Strategies to integrate multi-omics data for patient survival prediction

Deep learning assisted multi-omics integration for survival and drug-response prediction in breast cancer

Predicting censored survival data based on the interactions between meta-dimensional omics data in breast cancer

Integrative survival analysis of breast cancer with gene expression and DNA methylation data

DeepMOCCA: A pan-cancer prognostic model identifies personalized prognostic markers through graph attention and multi-omics data integration

Improving the robustness and stability of a machine learning model for breast cancer prognosis through the use of multi-modal classifiers

Automated real-world data integration improves cancer outcome prediction

Prognostically Relevant Subtypes and Survival Prediction for Breast Cancer Based on Multimodal Genomics Data

Toward Precision Breast Cancer Survival Prediction Utilizing Combined Whole Genome-Wide Expression and Somatic Mutation Analysis

Integrating PANoptosis insights to enhance breast cancer prognosis and therapeutic decision-making

Emphasizing the Role of Multi-omics Approach to Increase Survival Rate of Breast and Prostate Cancer Patients

Improving prediction performance of colon cancer prognosis based on the integration of clinical and multi-omics data